Risperidone for maintenance treatment of bipolar disorders
Brief summary
Evidence from systematic reviews
Further trials are needed which compare risperidone with other antipsychotics and moodstabilizers
What is the current evidence for the use of risperidone in the maintenance treatment of bipolar disorders?
There was only one small study conducted which compared risperidone to haloperidol as short-term treatment, but no differences between them are described and the results may be biased.Is there any group of patients that respond better to risperidone than the others?
Not described in the review.
Should risperidone be used as a single or combination treatment?
This is not clear from the evidence provided in the systematic reviews.What are the adverse events at short and long term?
This is not clear from the evidence provided in the systematic reviews.
For how long should risperidone (single or combination) be used?
Details not described in the review.
Is risperidone more efficacious than other mood stabilisers in the maintenance treatment of bipolar disorders?
This is not clear from the evidence provided in the systematic reviews.
Is the balance between harm and benefit favourable to the use of risperidone?
This is not clear from the evidence provided in the systematic reviews.
What type of research (if any) is needed to clarify the benefits and harms of using risperidone in the treatment of acute mania?
Further trials are needed which compare risperidone with other antipsychotics and mood stabilisers.
